AUSTIN, Texas, June 4, 2026 /PRNewswire/ -- Communication Service for the Deaf (CSD) announced today that it has appointed Karen Peltz Strauss to its...
BOSTON, June 4, 2026 /PRNewswire/ -- Researchers at Northeastern University's Institute for Intelligent Networked Systems (INSI) have developed GENESIS, an agentic AI framework that automates...
GREENWICH, Conn., June 4, 2026 /PRNewswire/ -- National Kidney Registry (NKR) is pleased to announce the nationwide rollout of the StrongBox®. The StrongBox® is a...
European Pension Investors Back Strategy Focused on Korea's Rapidly Expanding Rental Housing MarketNEW YORK, June 4, 2026 /PRNewswire/ -- Tishman Speyer today announced the...
SHANGHAI, June 4, 2026 /PRNewswire/ -- On June 3, the 19th (2026) International Photovoltaic Power Generation and Smart Energy Conference & Exhibition grandly opened...
BANNOCKBURN, Ill., June 04, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, announced the appointment of Robert Okunski as Vice President, Investor Relations effective May 26, 2026.
- Findings demonstrate strong correlation between CD45RC expression and lymphocytic infiltration in salivary glands, supporting its potential as both an early biomarker and therapeutic...
TAIPEI, June 4, 2026 /PRNewswire/ -- Compal Electronics (Compal; TWSE: 2324) showcases its landmark achievements in Quantum Technology and Advanced Artificial Intelligence (AI) at COMPUTEX...
Industry-academia collaboration brings hands-on AI learning and real-world technology exposure to students across three campusesCOIMBATORE, India, June 4, 2026 /PRNewswire/ -- Orion Innovation ("Orion"), a...
BRUSSELS, Belgium and CAMBRIDGE, Mass., June 04, 2026 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (Nasdaq: BIIB) today announced data, comprising two posters and three abstracts, at the European Alliance of Associations for Rheumatology (EULAR) 2026 Congress, demonstrating the clinical profile of dapirolizumab pegol (DZP), an investigational biologic in patients with systemic lupus erythematosus (SLE).
SHANGHAI, June 3, 2026 /PRNewswire/ -- On June 1 (Chicago time), in a Late-Breaking Abstract (LBA) oral presentation at the 2026 American Society of Clinical...